Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial
Sign Up to like & getrecommendations! Published in 2022 at "International Clinical Psychopharmacology"
DOI: 10.1097/yic.0000000000000415
Abstract: Mirtazapine upsurges serotonergic activity by a mechanism different from reuptake inhibition. Our aim is to assess the efficacy of mirtazapine augmentation for patients with obsessive-compulsive disorder (OCD) who did not respond to sertraline monotherapy. Sixty-one… read more here.
Keywords: obsessive compulsive; placebo; group; sertraline monotherapy ... See more keywords